India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Ozempic is available as a liquid in a prefilled multidose pen delivering doses of 0.25 milligrams (mg) or 0.5 mg and 1 mg. The pre-filled pen is injected in the abdominal, thigh, or upper arm area.

HYDERABAD, June 26 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ... and it was so ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 diabetes and chronic weight management ...

Danish company Novo Nordisk has launched Wegovy, its once-weekly weight-loss injection, in India as of June 24, 2025.

Semaglutide is the active ingredient in prefilled injectable pens sold under the brand names Ozempic and Wegovy, which many doctors prescribe for weight loss amid the obesity epidemic.

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced.

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced.